Adagio Medical Holdings (ADGM) EBITDA Margin (2023 - 2024)
Adagio Medical Holdings (ADGM) reported EBITDA Margin of 3352.27% for Q3 2024, up 1879651.0% on a YoY basis from N/an in Q4 2023, and down 27.87% sequentially from 2621.65% in Q2 2024.
Adagio Medical Holdings (ADGM) EBITDA Margin (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of EBITDA Margin data on file, last reported at 3352.27% in Q3 2024.
- For the quarter ending Q3 2024, EBITDA Margin rose 1879651.0% year-over-year to 3352.27%; the trailing twelve-month figure through Dec 2025 stood at 16517.42% (changed N/A YoY), and the FY2024 full-year result was 23226.77%, down 1391277.0% from the prior year.
- EBITDA Margin fell to 3352.27% in Q3 2024, from 2621.65% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 2621.65% in Q2 2024 to a low of 33903.85% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | 10.04% |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 21.42% |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 6.17% |
| 10 | Adagio Medical Holdings | 21.08 Mn | 21.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3,352.27% |
| Jun 30, 2024 | -2,621.65% |
| Mar 31, 2024 | -33,903.85% |
| Dec 31, 2023 | -6,837.18% |
| Sep 30, 2023 | -22,148.78% |